COX inhibition in human whole blood
Cell-based study · Human whole blood from healthy Japanese volunteers aged 20–40 years; 8 male and 10 female participants enrolled [1]
Both prostanoid readouts were inhibited with increasing concentration; the COX-2 IC50 was lower. This cellular blood assay measures functional COX activity rather than direct binding.
| Endpoint | Reported result | Reference |
|---|---|---|
| TXB2 production, COX-1 assay | IC50 36.2 ng/mL | [1] |
| PGE2 production, COX-2 assay | IC50 13.5 ng/mL | [1] |
| TXB2 production, COX-1 assay | IC80 294.4 ng/mL | [1] |
| PGE2 production, COX-2 assay | IC80 51.3 ng/mL | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 4.12–1000 ng/mL final diclofenac sodium
- Exposure duration
- COX-1: 1 h; COX-2: 24 h
- Method
- Whole-blood prostanoid assays; COX-2 readout after aspirin pretreatment and inflammatory stimulation
- Vehicle
- DMSO
- Co-treatment
- Aspirin pretreatment is an assay control for the COX-2 readout, not an efficacy combination.
- Reported limits
- Figure 1 reports mean ± SE for five samples; donor-to-sample independence is not fully clarified. No uncertainty intervals accompany Figure 2 IC values.
Methods and source locations
Compound reported in the paper: Diclofenac sodium; Compound label in the paper: FUJIFILM Wako Pure Chemical material
Sodium-salt functional COX inhibition in human blood; no conversion of units or clinical dosing inference.
Methods: Preparation of Samples, COX-1 and COX-2 Assays, Calculation of Inhibition Rates, Statistical Analysis; Figure 1a and caption; Figure 2 labeled IC50/IC80 lines; Discussion limitations
TXB2 production, COX-1 assay: ELISA and logistic fit — Figure 2, labeled COX-1 IC50 line
PGE2 production, COX-2 assay: ELISA and logistic fit — Figure 2, labeled COX-2 IC50 line
TXB2 production, COX-1 assay: ELISA and logistic fit — Figure 2, labeled COX-1 IC80 line
PGE2 production, COX-2 assay: ELISA and logistic fit — Figure 2, labeled COX-2 IC80 line